Zrc Wealth Management, LLC Akero Therapeutics, Inc. Transaction History
Zrc Wealth Management, LLC
- $237 Billion
- Q4 2024
A detailed history of Zrc Wealth Management, LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Zrc Wealth Management, LLC holds 60 shares of AKRO stock, worth $2,614. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60
Previous 60
-0.0%
Holding current value
$2,614
Previous $1.72 Million
3.02%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AKRO
# of Institutions
209Shares Held
66.9MCall Options Held
321KPut Options Held
558K-
Rtw Investments, LP New York, NY6.86MShares$299 Million3.11% of portfolio
-
Janus Henderson Group PLC London, X06.03MShares$263 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$243 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$228 Million5.21% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.32MShares$188 Million0.01% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.02B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...